Dr. Glass joined HRI in early 2019 with a wealth of experience in clinical research and a strong background in psychiatric indications. He conducts trials at both the Marlton and Berlin locations. Dr. Glass has over 17 years of experience as a principal investigator, executing and overseeing early phase trials in both healthy and disease state subjects, as well as late-stage trials.
Dr. Glass has participated in almost 400 trials, including almost 75 Phase I and IIa trials. His study experience includes all major psychiatric indications as well as many pain and addictions and abuse liability trials. Dr. Glass came to HRI from Intra-Cellular Therapies where he was Senior Medical Director from 2015 to 2019. Prior to ITCI, he was Psychiatric Medical Director at PRA Health Sciences. He had been with CRI Lifetree, before its acquisition by PRA, as Psychiatric Medical Director and Principal Investigator since 1999. Dr. Glass has been in private practice as a psychiatrist for the past 40 years. He has treated many of the patients who have been enrolled in trials at HRI.
Dr. Glass received his medical degree from Thomas Jefferson Medical College in Philadelphia (now Sidney Kimmel Medical College of Jefferson University) where he also completed his psychiatric residency and Chief Resident responsibilities. He received his B.A. (Major in Biology, Minors in Chemistry and Psychology) from Swarthmore College in Swarthmore, PA.